Considering the multifaceted role of CAFs in driving the progression of breast cancer [26], we evaluated GPR30-mediated CAF-induced effects on TAM resistance, finding that TAM upregulated the expression and secretion of HMGB1 via GPR30/PI3K/AKT signaling in CAFs. The gene discussed is AKT1; the disease is breast carcinoma.